• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, November 30, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Chinese scientists discover biomimetic macrophage technology to combat antibiotic resistance

Bioengineer by Bioengineer
September 28, 2023
in Science News
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A research team led by Shuilin Wu at Tianjin University, China, has made a groundbreaking discovery in the field of intelligent catalysis. Their research article titled “Biomimetic Macrophage–Fe3O4@PLGA Particle-Triggered Intelligent Catalysis for Killing Multidrug-Resistant Escherichia coli” has been published in the journal Engineering.

Intelligent catalysis-therapeutic schematics of MΦ–Fe3O4@PLGA particles.

Credit: Jieni Fu et al.

A research team led by Shuilin Wu at Tianjin University, China, has made a groundbreaking discovery in the field of intelligent catalysis. Their research article titled “Biomimetic Macrophage–Fe3O4@PLGA Particle-Triggered Intelligent Catalysis for Killing Multidrug-Resistant Escherichia coli” has been published in the journal Engineering.

Infections caused by multidrug-resistant (MDR) Gram-negative bacteria, such as MDR Escherichia coli (E. coli), pose a significant challenge to healthcare professionals worldwide. The lack of safe antibiotics and the high fatality rates associated with anti-infection therapies have prompted researchers to explore innovative solutions. The research team at Tianjin University has developed a biomimetic intelligent catalysis approach inspired by the selective biocatalytic property of macrophages, which shows promise in combating MDR E. coli infections without harming normal cells.

The intelligent catalysis system consists of two main components: a living macrophage (MΦ) acting as an intelligent controlling center and Fe3O4@poly(lactic-co-glycolic acid) (PLGA) nanoparticles functioning as a Fenton reaction catalyst. The MΦ–Fe3O4@PLGA particles, also referred to as intelligent catalysis particles, exhibit selective biocatalysis activity against MDR E. coli by producing hydrogen peroxide (H2O2) and lipid droplets (LDs). RNA sequencing data analysis revealed that this process activates lipid metabolism and glycan biosynthesis and metabolism pathways.

The H2O2 generated by the intelligent catalysis particles reacts with Fe3O4@PLGA to form highly toxic hydroxyl radicals (•OH), while the LDs contain antimicrobial peptides that specifically target MDR E. coli. The combination of •OH and antimicrobial peptides effectively combats MDR E. coli, resulting in an impressive antibacterial efficiency of 99.29% ± 0.31% in vitro. Furthermore, the intelligent catalysis function of the MΦ–Fe3O4@PLGA particles remains intact even after several passages, indicating their long-term effectiveness.

The potential of biomimetic intelligent catalysts extends beyond the treatment of infections caused by MDR bacteria. The concept holds promise for addressing other diseases as well. The research team’s findings pave the way for the development of innovative therapies that leverage the properties of macrophages and nanoparticles to combat various diseases.

Nan Zhang, editor of the subject of chemical, metallurgical, and materials engineering of Engineering, expressed optimism about the future of biomimetic intelligent catalysis. “This research demonstrates the remarkable potential of MΦ–Fe3O4@PLGA particles as effective and safe antibacterial agents. The fact that PLGA and Fe3O4 nanoparticles have already been approved for use in humans by the US FDA further enhances the prospects of its approach for clinical applications.”

While the research presents exciting possibilities, the clinical application of living cells is currently limited by culturing conditions. However, the team’s pioneering work serves as a foundation for further exploration and development of biomimetic intelligent catalysis systems for a wide range of diseases.

The paper “Biomimetic Macrophage–Fe3O4@PLGA Particle-Triggered Intelligent Catalysis for Killing Multidrug-Resistant Escherichia coli”, authored by Jieni Fu, Xiangmei Liu, Zhaoyang Li, Yufeng Zheng, Yu Zhang, Hui Jiang, Yanqin Liang, Shengli Zhu, Zhenduo Cui, Shuilin Wu. Full text of the open access paper: https://doi.org/10.1016/j.eng.2023.05.022. For more information about the Engineering, follow us on Twitter (https://twitter.com/EngineeringJrnl) & like us on Facebook (https://www.facebook.com/EngineeringPortfolio).

 

About Engineering

Engineering (ISSN: 2095-8099 IF:12.8) is an international open-access journal that was launched by the Chinese Academy of Engineering (CAE) in 2015. Its aims are to provide a high-level platform where cutting-edge advancements in engineering R&D, current major research outputs, and key achievements can be disseminated and shared; to report progress in engineering science, discuss hot topics, areas of interest, challenges, and prospects in engineering development, and consider human and environmental well-being and ethics in engineering; to encourage engineering breakthroughs and innovations that are of profound economic and social importance, enabling them to reach advanced international standards and to become a new productive force, and thereby changing the world, benefiting humanity, and creating a new future.



Journal

Engineering

DOI

10.1016/j.eng.2023.05.022

Article Title

Biomimetic Macrophage–Fe3O4@PLGA Particle-Triggered Intelligent Catalysis for Killing Multidrug-Resistant Escherichia coli

Article Publication Date

29-Aug-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

Illustration of a droplet

Protected droplets a new transport route for medicines

November 30, 2023
Composition panels

Rice husk and recycled newspaper may be the eco-friendly insulation material of the future

November 30, 2023

Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance

November 30, 2023

What is Cellular Agriculture? The world population is expected to reach 9.7 billion by 2050. With it will come a doubling in the amount of animal protein we consume.

November 30, 2023

POPULAR NEWS

  • Figure 1

    Understanding rapid tendon regeneration in newts may one day help human athletes

    77 shares
    Share 31 Tweet 19
  • Study finds increasingly popular oral nicotine pouches do little to curb smokers’ cravings

    35 shares
    Share 14 Tweet 9
  • SMART researchers pioneer novel microfluidic method to optimise bone marrow stem cell extraction for advanced cell therapies

    34 shares
    Share 14 Tweet 9
  • UMass Amherst receives $2.5 million from Howard Hughes Medical Institute to reshape STEM education

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Protected droplets a new transport route for medicines

Rice husk and recycled newspaper may be the eco-friendly insulation material of the future

Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 58 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In